LICORbio

LICORbio is a private, revenue-generating company that develops and commercializes a comprehensive suite of imaging instruments, consumable reagents, and analysis software for the life sciences research market. Its core value proposition is providing scientists with highly sensitive, quantitative, and reproducible data across a wide range of applications, from traditional Western blots to cutting-edge 3D organoid imaging. The company has established a strong reputation, with its instruments cited in over 75,000 peer-reviewed publications, and operates a direct e-commerce sales model. LICORbio is strategically positioned at the intersection of diagnostics tools and digital health through its integrated hardware-software systems.

Integrated platform of advanced optical imaging systems (infrared/NIR), proprietary reagents/consumables, and analysis software for quantitative life science research.

LICORbio competes in the bioimaging and protein analysis market against companies like Bio-Rad Laboratories, Azure Biosystems, and Cytiva. Its key differentiators are its established reputation for quantitative accuracy, wide dynamic range, and an integrated ecosystem of hardware, software, and proprietary reagents designed to work optimally together.